TY - JOUR
T1 - Impact of chronic and acute inflammation on extra- and intracellular iron homeostasis
AU - Catharine Ross, A.
N1 - Funding Information:
Presented at the workshop “Iron Screening and Supplementation in Iron-Replete Pregnant Women and Young Children” held by the NIH Office of Dietary Supplements, Bethesda, MD, 28–29 September 2016. Supported by NIH HD-066982 and DK-41479 and a Dorothy Foehr Huck Endowment. Address correspondence to ACR (e-mail: acr6@psu.edu). Abbreviations used: AGP, a1-acid glycoprotein; AP, acute phase; APR, acute phase response; CRP, C-reactive protein; FPN, ferroportin; HAMP, hepcidin antimicrobrial peptide; HO-1, heme oxygenase 1; RBC, red blood cell; SAA, serum amyloid protein. First published online October 25, 2017; doi: https://doi.org/10.3945/ajcn. 117.155838.
Publisher Copyright:
© 2017 Oxford University Press. All rights reserved.
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Inflammation has a major impact on iron homeostasis. This review focuses on acute and chronic inflammation as it affects iron trafficking and, as a result, the availability of this essential micronutrient to the host. In situations of microbial infection, not only the host is affected but also the offending microorganisms, which, in general, not only require iron for their own growth but have evolved mechanisms to obtain it from the infected host. Key players in mammalian iron trafficking include several types of cells important to iron acquisition, homeostasis, and hematopoiesis (enterocytes, hepatocytes, macrophages, hematopoietic cells, and in the case of pregnancy, placental syncytiotrophoblast cells) and several forms of chaperone proteins, including, for nonheme iron, the transport protein transferrin and the intracellular iron-storage protein ferritin, and for heme iron, the chaperone proteins haptoglobin and hemopexin. Additional key players are the cell membrane-associated iron transporters, particularly ferroportin (FPN), the only protein known to modulate iron export from cells, and finally, the iron-regulatory hormone hepcidin, which, in addition to having antibacterial activity, regulates the functions of FPN. Interestingly, the impact of infection on iron homeostasis differs among pathogens whose mode of infection is mainly intracellular or extracellular. Understanding how inflammation affects each of these processes may be crucial for understanding how inflammation affects iron status, indicators of iron sufficiency, and iron supplementation during inflammation and how it may potentially result in a beneficial or detrimental impact on the host.
AB - Inflammation has a major impact on iron homeostasis. This review focuses on acute and chronic inflammation as it affects iron trafficking and, as a result, the availability of this essential micronutrient to the host. In situations of microbial infection, not only the host is affected but also the offending microorganisms, which, in general, not only require iron for their own growth but have evolved mechanisms to obtain it from the infected host. Key players in mammalian iron trafficking include several types of cells important to iron acquisition, homeostasis, and hematopoiesis (enterocytes, hepatocytes, macrophages, hematopoietic cells, and in the case of pregnancy, placental syncytiotrophoblast cells) and several forms of chaperone proteins, including, for nonheme iron, the transport protein transferrin and the intracellular iron-storage protein ferritin, and for heme iron, the chaperone proteins haptoglobin and hemopexin. Additional key players are the cell membrane-associated iron transporters, particularly ferroportin (FPN), the only protein known to modulate iron export from cells, and finally, the iron-regulatory hormone hepcidin, which, in addition to having antibacterial activity, regulates the functions of FPN. Interestingly, the impact of infection on iron homeostasis differs among pathogens whose mode of infection is mainly intracellular or extracellular. Understanding how inflammation affects each of these processes may be crucial for understanding how inflammation affects iron status, indicators of iron sufficiency, and iron supplementation during inflammation and how it may potentially result in a beneficial or detrimental impact on the host.
UR - http://www.scopus.com/inward/record.url?scp=85037641137&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85037641137&partnerID=8YFLogxK
U2 - 10.3945/ajcn.117.155838
DO - 10.3945/ajcn.117.155838
M3 - Article
C2 - 29070546
AN - SCOPUS:85037641137
SN - 0002-9165
VL - 106
SP - 1581S-1587S
JO - American Journal of Clinical Nutrition
JF - American Journal of Clinical Nutrition
ER -